GlassScriptPhysician profile
Sridhar K Iyer
NPI 1043299712
$16,915.85
in general payments reported to CMS, 2019-2025
46 companies · $1,679 in 2025
The $1,679 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $881 · 2020: $764 · 2021: $470 · 2022: $919 · 2023: $11K · 2024: $1,176 · 2025: $1,679.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $9,285 · Food and Beverage: $3,212 · Travel and Lodging: $1,385.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $9,284.97 |
| Food and Beverage | $3,211.63 |
| Travel and Lodging | $1,384.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,747.90 | 2023-2025 | Da Vinci Surgical System, Ion |
| Glaxosmithkline, LLC. | $1,217.54 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Olympus Corporation of The Americas | $878.95 | 2023 | Single Use Suction Valve (Sterile) |
| Astrazeneca Pharmaceuticals LP | $665.81 | 2019-2025 | Fasenra, Airsupra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $536.38 | 2019-2025 | Ofev, Jascayd, Stiolto Respimat |
| Mallinckrodt Hospital Products INC. | $500.23 | 2020-2025 | Acthar |
| Grifols USA, LLC | $460.09 | 2019-2025 | Xembify, Prolastin-C Liquid |
| Takeda Pharmaceuticals U.S.A., INC. | $319.97 | 2020-2025 | Glassia, Hyqvia, Cuvitru |
| Philips North America LLC | $270.28 | 2019-2024 | (Bo0) Hosp Vent Devices |
| Regeneron Healthcare Solutions, INC. | $265.37 | 2021-2025 | Dupixent |
| United Therapeutics Corporation | $198.40 | 2019-2025 | Orenitram, Tyvaso, Tyvaso |
| Amgen INC. | $188.98 | 2022-2025 | Tezspire |
| Harmony Biosciences LLC | $170.72 | 2022-2025 | Wakix |
| Actelion Pharmaceuticals US, INC. | $164.07 | 2019-2025 | Opsumit |
| Ani Pharmaceuticals, INC. | $136.46 | 2022-2024 | Purified Cortrophin Gel |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $127.11 | 2019-2023 | Yupelri |
| Baxter Healthcare | $117.84 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Electromed, INC. | $100.89 | 2021-2025 | Smartvest |
| Insmed, INC. | $79.51 | 2020-2025 | Arikayce, Brinsupri |
| Mallinckrodt Enterprises LLC | $66.34 | 2019 | |
| Sunovion Pharmaceuticals INC. | $57.20 | 2019 | |
| Pfizer INC. | $50.10 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $48.32 | 2019-2024 | Winrevair |
| Ethicon INC. | $44.99 | 2022 | |
| Genzyme Corporation | $40.79 | 2020-2025 | |
| Viatris Specialty LLC | $39.93 | 2025 | Yupelri |
| Boston Scientific Corporation | $33.95 | 2025 | Wavewriter Alpha Prime 16 |
| Shire North American Group INC | $33.77 | 2019 | |
| Verona Pharma, INC. | $33.00 | 2025 | Ohtuvayre |
| Tactile Systems Technology INC | $32.46 | 2022 | |
| Genentech USA, INC. | $31.88 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $25.28 | 2021 | |
| Abbvie INC. | $23.31 | 2024 | |
| Resmed Corp | $21.11 | 2020 | |
| Optinose US, INC. | $20.16 | 2024 | |
| Ars Pharmaceuticals Operations, INC. | $19.41 | 2025 | Neffy |
| Pulmonx Corporation | $18.54 | 2024 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| 3b Medical, INC. | $16.93 | 2025 | Luna |
| Lilly USA, LLC | $16.60 | 2025 | Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $16.35 | 2019 | |
| Eisai INC. | $15.23 | 2021 | |
| Inogen, INC. | $14.82 | 2022 | |
| Novartis Pharmaceuticals Corporation | $14.50 | 2019 | |
| Paratek Pharmaceuticals, INC. | $13.01 | 2023 | Nuzyra |
| Csl Behring | $12.95 | 2019 | |
| Veran Medical Technologies, INC. | $8.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sridhar Iyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.